Important Safety Information

BEXSERO® multicomponent meningococcal B vaccine (recombinant, adsorbed) is a vaccine for the prevention of meningococcal disease caused by Neisseria meningitidis group B bacteria in individuals from 2 months through 17 years of age. BEXSERO® is not expected to provide protection against all circulating meningococcal serogroup B strains and does not offer protection against strains A, C, Y, and W-135. As with any vaccine, BEXSERO® may not fully protect all of those who are vaccinated. BEXSERO® does not treat or reduce the consequences of meningococcal meningitidis, including meningitis, sepsis, and death. The very common side effects (may affect more than 1 in 10 people) after vaccination with BEXSERO® were pain/tenderness at the injection site, redness at the injection site, swelling of the skin at the injection site, and hardness of the skin at the injection site. In infants and children (up to 10 years of age), fever can occur more frequently when BEXSERO® is given at the same time as routine infant vaccines. Allergic reactions may also occur. Discuss the advantages and disadvantages of BEXSERO® with your healthcare professional in advance of receiving the vaccine. Full product information can be found on myg.sk/bexsero. To report an adverse event, please call 1-800-387-7374.